Allyl isothiocyanate (AITC) has been reported to exhibit antimetastatic activity, but the mechanism remains unclear. The objective of this study was to determine the effect of AITC on cell adhesion, migration, and metalloproteinase gene expression in SK-Hep1 human hepatoma cells. The gene expression profiles of SK-Hep1 cells were obtained by using the HG-U133A Affymetrix GeneChip human genome array containing 14,500 human genes. Twenty antimetastatic genes including COL4A3, ADAMDEC1, CAPN10, CD14, and ITGB1BP3 were over expressed, while the expression of 35 genes such as COL8A1, MYBPC1, ST14, and SOS2 were down-regulated. Semiquantitative RT-PCR confirmed these results in mRNA levels. Based on these in vitro results, it can be concluded that AITC might be potentially useful in suppressing tumor cell migration and MMP expression.
Get full access to this article
View all access options for this article.
References
1.
Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr132:2991–2994, 2002.
2.
Munday R, Munday CM. Selective induction of phase II enzymes in the urinary bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables. Nutr Cancer44:52–59, 2002.
3.
Hwang E, Lee HJ. Induction of quinine reductase by allylisothiocyanate (AITC) and the N-acetylcysteine conjugate of AITC in Hepa1c1c7 mouse hepatoma cells. Biofactors26:7–15, 2006.
4.
Manesh C, Kuttan G. Effect of naturally occurring allyl and phenyl isothiocyanates in the inhibition of experimental pulmonary metastasis induced by B16F-10 melanoma cells. Fitoterapia74:355–363, 2003.
5.
Price JT, Thompson EW. Mechanisms of tumor invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets6: 217–233, 2002.
6.
Simpson-Haidaris PJ, Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Ann N Y Acad Sci936: 406–425, 2001.
7.
Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ES. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol50:87–100, 2004.
8.
Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev23:101–117, 2004.
9.
Bucca G, Garruba G, Saetta A, Muti P, Castagnetta L, Smith CP. Gene expression profiling of human cancers. Ann N Y Acad Sci1028:28–37, 2004.
10.
Tothill RW, Kowalczyk A, Rischin D, Bousioutas A, Haviv I, van Laar RK, Waring PM, Zalcberg J, Ward R, Biankin AV, Sutherland RL, Henshall SM, Fong K, Pollack JR, Bowtell DD, Holloway AJ. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res65:4031–4040, 2005.
11.
Fukui R, Nishimori H, Hata F, Yasoshima T, Ohno K, Nomura H, Yanai Y, Tanaka H, Kamiguchi K, Denno R, Sato N, Hirata K. Metastases-related genes in the classification of liver and peritoneal metastasis in human gastric cancer. J Surg Res129:94–100, 2005.
12.
Uematsu F, Takahashi M, Yoshida M, Igarashi M, Watanabe N, Suzuki N, Abe M, Rusyn I, Rloyd RA, Nakae D. Distinct patterns of gene expression in hepatocellular carcinomas and adjacent non-cancerous, cirrhotic liver tissues in rats fed a choline-deficient, L-amino acid-defined diet. Cancer Sci96:414–424, 2005.
13.
Novakovic P, Stempak JM, Sohn KJ, Kim YI. Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis27:916–924, 2006.
14.
Kumagai T, Tomari K, Shimizu T, Takeda K. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells. Int J Mol Med17: 285–291, 2006.
15.
Mao HJ, Li HN, Zhou XM, Zhao JL, Wan DF. Monitoring microarray-based gene expression profile changes in hepatocellular carcinoma. World J Gastroenterol11:2811–2816, 2005.
16.
Veeriah S, Kautenburger T, Habermann N, Sauer J, Dietrich H, Will F, Pool-Zobel BL. Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobiotics. Mol Carcinog45:164–174, 2006.
17.
Hwang E, Lee HJ. Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep1 human hepatoma cells. Exp Biol Med231:421–430, 2006.
18.
Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo. Carcinogenesis24:1665–1670, 2003.
19.
Laky B, Knasmuller S, Gminski R, Mersch-Sundermann V, Scharf G, Verkerk R, Freywald C, Uhl M, Kassie F. Protective effects of Brussels sprouts towards B[a]P-induced DNA damage: a model study with the single-cell gel electrophoresis (SCGE)/Hep G2 assay. Food Chem Toxicol40:1077–1083, 2002.
20.
Kashtan CE. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine78:338–360, 1999.
21.
Shi YE, Torri J, Yieh L, Wellstein A, Lippman ME, Dickson RB. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res53: 1409–1415, 1993.
22.
Lin CY, Anders J, Johnson M, Sang QA, Dickson RB. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem274:18231–18236, 1999.
23.
Ding KF, Sun LF, Ge WT, Hu HG, Zhang SZ, Zheng S. Effect of SNC19/ST14 gene overexpression on invasion of colorectal cancer cells. World J Gastroenterol28:5651–5654, 2005.
24.
Annabi B, Bouzeghrane M, Currie JC, Hawkins R, Dulude H, Daigneault L, Ruiz M, Wisniewski J, Garde S, Rabbani SA, Panchal C, Wu JJ, Beliveau R. A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. Clin Exp Metastasis22:429–439, 2005.
25.
Tajima M, Hirabayashi S, Yao I, Shirasawa M, Osuga J, Ishibashi S, Fujita T, Hata Y. Roles of immunoglobulin-like loops of junctional cell adhesion molecule 4; involvement in the subcellular localization and the cell adhesion. Genes Cells8:759–768, 2003.
26.
Beier UH, Gorogh T, Holtmeier C, Ambrosch P, Maune S. Over-expression of the human myosin-binding protein-C1 mRNA in laryngeal squamous cell carcinoma cells. Anticancer Res22: 3343–3347, 2002.
27.
Xiao Z, Goldsmith HL, McIntosh FA, Shankaran H, Neelamegham S. Biomechanics of P-selectin PSGL-1 bonds: shear threshold and integrin-independent cell adhesion. Biophys J90:2221–2234, 2006.
28.
Kragh M, Loechel F. Non-anti-coagulant heparins: a promising approach for prevention of tumor metastasis. Int J Oncol27: 1159–1167, 2005.
29.
Wilson CL, Heppner KJ, Labosky PA, Hogan BLM, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A94:1402–1407, 1999.
30.
Martinez C, Bhattacharya S, Freeman T, Churchman M, Ilyas M. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (MMP) genes. J Pathol206:100–110, 2005.
